SEARCH

PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Thursday, May 25, 2017

BRCA

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1781 Ex Parte Gansen et al 14410757 - (D) DENNETT 112(1) STAAS & HALSEY LLP VONCH, JEFFREY A

Tech Center 2100 Computer Architecture and Software
2127 Ex Parte Feigenbaum et al 13691816 - (D) SHIANG 103 LAW OFFICE OF IDO TUCHMAN (AUS) AZAD, MD ABUL K

Tech Center 2100 Computer Architecture and Software
2144 Ex Parte Creamer et al 11382315 - (D) McCOLLUM 103 CRGO LAW STORK, KYLE R

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2479 Ex Parte Lakkis et al 12483987 - (D) JURGOVAN 103 QUALCOMM INCORPORATFD CEHIC, KENAN

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3724 Ex Parte Wain et al 13006816 - (D) WIEKER 103 THE PROCTER & GAMBLE COMPANY PAYER, HWEI-SIU C

3731 Ex Parte Elliott 14068509 - (D) FLAX 102/103 KACVINSKY DAISAK BLUNI PLLC YABUT, DIANE D

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1652 Ex Parte Lukyanov et al 11607828 - (D) CHANG 112(1)/101 101 BOZICEVIC, FIELD & FRANCIS LLP ROBINSON, HOPE A

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2868 Ex Parte Wong et al 12972791 - (D) PER CURIAM 103 103 Keysight Technologies, Inc. NATALINI, JEFF WILLIAM

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1615 Ex Parte Shah et al 13622636 - (D) CHANG 112(2) 103 UNILEVER PATENT GROUP WAX, ROBERT A

1615 Ex Parte Molenda et al 13515440 - (D) CHANG 103 NORRIS MCLAUGHLIN & MARCUS, PA AL-AWADI, DANAH J

1644 Ex Parte Robinson et al 12214670 - (D) MAJORS 112(1)/112(2) 101/103 Bozicevic, Field & Francis LLP Stanford University Office of Technology Licensing EWOLDT, GERALD R

Given this broad disclosure, even if claim 1 did not foreclose certain combinations of cytokines and autoantibodies at present, the draftsperson may pursue these combinations through future claims, thus expanding the preemptive reach of Appellants’ invention drawn to the natural law.10 Cf. In re BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litig., 774 F.3d 755, 764 n. 4 (Fed. Cir. 2014) (“The preemptive nature of the claims is not ameliorated even if we accept Myriad’s argument that other methods of comparison exist. If the combination of certain routine steps were patent eligible, so too would different combinations of other routine steps.”)

BRCA1– and BRCA2–Based Hereditary Cancer Test Patent Litigation, In re, 774 F.3d 755, 113 USPQ2d 1241 (Fed. Cir. 2014) 2106

1651 Ex Parte Blau et al 13440534 - (D) MILLS 103 Bozicevic, Field & Francis LLP Stanford University Office of Technology Licensing VISONE, THOMAS J

Tech Center 1700 Chemical & Materials Engineering
1787 Ex Parte Wantling 13692376 - (D) NAGUMO 103 Hexion Inc. SHUKLA, KRUPA

1793 Ex Parte Gan et al 12265559 - (D) FRANKLIN 103 FITCH EVEN TABIN & FLANNERY, LLP TURNER, FELICIA C

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2442 Ex Parte Abdelhadi et al 12564151 - (D) POTHIER 103 Rolnik Law Firm, P.C. IBM Corp. (AUS/RCR) MACILWINEN, JOHN MOORE JAIN

2463 Ex Parte Kwon et al 13925365 - (D) JEFFERY 102/103 Slater Matsil, LLP ANWAR, MOHAMMAD S

2466 Ex Parte KIM et al 12349882 - (D) DROESCH 103 THE FARRELL LAW FIRM, P.C. LINDENBAUM, ALAN LOUIS

2472 Ex Parte Luo et al 13777618 - (D) BUI 103 BGL/Huawei MUSA, ABDELNABI O

Tech Center 2600 Communications
2612 Ex Parte MATTILA et al 14157984 - (D) EVANS 101 103 Ditthavong & Steiner, P.C. NGUYEN, KIMBINH T

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3612 Ex Parte RUSS 14225890 - (D) AMUNDSON, 102 MAIER & MAIER, PLLC PATEL, KIRAN B

3643 Ex Parte HUNG 13729071 - (D) CALVE 102/103 BROOKS KUSHMAN P.C. BURGESS, MARC R

3667 Ex Parte Dwan et al 13558804 - (D) ENGLE 102 BROOKS KUSHMAN P.C. /FGTL BADII, BEHRANG

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Contiliano et al 13494395 - (D) NEW 103 Roberts Mlotkowski Safran Cole & Calderon, P.C. OU, JING RUI

3754 Ex Parte Selover 11110262 - (D) OSINSKI 103 41.50 103 Carlson, Gaskey & Olds/Masco Corporation LE, HUYEN D

3771 Ex Parte GUNARATNAM et al 11962621 - (D) HOELTER 103 NIXON & VANDERHYE, PC STANIS, TIMOTHY A

No comments :